US FDA Guidance Redefines Obesity, But Keeps 2007 Efficacy Standard

The FDA did not update its efficacy expectations for weight loss drugs in new draft guidance. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from R&D